147 related articles for article (PubMed ID: 34155797)
1. Hepatocellular Carcinomas: Towards a pathomolecular approach.
Paradis V
Liver Int; 2021 Jun; 41 Suppl 1():83-88. PubMed ID: 34155797
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
[TBL] [Abstract][Full Text] [Related]
3. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinomas and their mimics].
Fischer HP; Goltz D
Pathologe; 2019 Feb; 40(1):101-118. PubMed ID: 30706100
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of hepatocellular adenoma: report of a case.
Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter mutations in primary liver tumors.
Nault JC; Zucman-Rossi J
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):9-14. PubMed ID: 26336998
[TBL] [Abstract][Full Text] [Related]
7. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.
Liu TC; Vachharajani N; Chapman WC; Brunt EM
Mod Pathol; 2014 Mar; 27(3):420-32. PubMed ID: 24051694
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver.
Burri E; Steuerwald M; Cathomas G; Mentha G; Majno P; Rubbia-Brandt L; Meier R
Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):437-41. PubMed ID: 16538118
[TBL] [Abstract][Full Text] [Related]
9. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.
Zulfiqar M; Sirlin CB; Yoneda N; Ronot M; Hecht EM; Chernyak V; Matsui O; Bastati N; Ba-Ssalamah A; Chatterjee D; Bashir M; Fowler KJ
J Magn Reson Imaging; 2020 Jun; 51(6):1630-1640. PubMed ID: 31418986
[TBL] [Abstract][Full Text] [Related]
11. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.
Bossen L; Grønbaek H; Lykke Eriksen P; Jepsen P
Liver Int; 2017 Jul; 37(7):1042-1046. PubMed ID: 28317318
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Pilati C; Letouzé E; Nault JC; Imbeaud S; Boulai A; Calderaro J; Poussin K; Franconi A; Couchy G; Morcrette G; Mallet M; Taouji S; Balabaud C; Terris B; Canal F; Paradis V; Scoazec JY; de Muret A; Guettier C; Bioulac-Sage P; Chevet E; Calvo F; Zucman-Rossi J
Cancer Cell; 2014 Apr; 25(4):428-41. PubMed ID: 24735922
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular tumours in noncirrhotic liver tissue].
Goltz D; Fischer HP
Pathologe; 2015 Nov; 36(6):597-606; quiz 607-8. PubMed ID: 26496997
[TBL] [Abstract][Full Text] [Related]
14. Clonal xenobiotic resistance during pollution-induced toxic injury and hepatocellular carcinogenesis in liver of female flounder (Platichthys flesus (L.)).
Koehler A; Alpermann T; Lauritzen B; Van Noorden CJ
Acta Histochem; 2004; 106(2):155-70. PubMed ID: 15147637
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.
González-Lara MF; Córdova-Ramón JC; Gamboa-Domínguez A; Cosme-Labarthe J; Carrillo-Pérez DL
Ann Hepatol; 2013; 12(4):626-8. PubMed ID: 23813141
[TBL] [Abstract][Full Text] [Related]
16. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease.
Nakanuma Y; Hirata K; Terasaki S; Ueda K; Matsui O
Histol Histopathol; 1998 Oct; 13(4):1077-87. PubMed ID: 9810504
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver.
Seo JM; Lee SJ; Kim SH; Park CK; Ha SY
Clin Radiol; 2012 Apr; 67(4):329-33. PubMed ID: 22079485
[TBL] [Abstract][Full Text] [Related]
18. Natural history of liver adenomatosis: A long-term observational study.
Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
[TBL] [Abstract][Full Text] [Related]
19. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
